These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37314412)

  • 21. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
    J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors.
    Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Spicing up" of the immune system by curcumin.
    Jagetia GC; Aggarwal BB
    J Clin Immunol; 2007 Jan; 27(1):19-35. PubMed ID: 17211725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
    Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
    J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
    Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review.
    Hosseini A; Hosseinzadeh H
    Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.
    Colin P; Bénureau Y; Staropoli I; Wang Y; Gonzalez N; Alcami J; Hartley O; Brelot A; Arenzana-Seisdedos F; Lagane B
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9475-80. PubMed ID: 23696662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric).
    Kim K; Kim JJ; Jung Y; Noh JY; Syed AS; Kim CY; Lee MY; Lim KM; Bae ON; Chung JH
    J Nat Prod; 2017 Jan; 80(1):196-200. PubMed ID: 28068085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of chemokine-mediated block to HIV entry with coreceptor internalization.
    Brandt SM; Mariani R; Holland AU; Hope TJ; Landau NR
    J Biol Chem; 2002 May; 277(19):17291-9. PubMed ID: 11782464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals.
    Rosati M; Valentin A; Patenaude DJ; Pavlakis GN
    J Immunol; 2001 Aug; 167(3):1654-62. PubMed ID: 11466389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
    O'Brien TR; McDermott DH; Ioannidis JP; Carrington M; Murphy PM; Havlir DV; Richman DD
    AIDS; 2000 May; 14(7):821-6. PubMed ID: 10839590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lupane-type triterpene 30-oxo-calenduladiol is a CCR5 antagonist with anti-HIV-1 and anti-chemotactic activities.
    Barroso-González J; El Jaber-Vazdekis N; García-Expósito L; Machado JD; Zárate R; Ravelo ÁG; Estévez-Braun A; Valenzuela-Fernández A
    J Biol Chem; 2009 Jun; 284(24):16609-16620. PubMed ID: 19386595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.
    Kang Y; Wu Z; Lau TC; Lu X; Liu L; Cheung AK; Tan Z; Ng J; Liang J; Wang H; Li S; Zheng B; Li B; Chen L; Chen Z
    J Biol Chem; 2012 May; 287(20):16499-509. PubMed ID: 22447925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
    J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A transcriptomic analysis of turmeric: Curcumin represses the expression of cholesterol biosynthetic genes and synergizes with simvastatin.
    Einbond LS; Manservisi F; Wu HA; Balick M; Antonetti V; Vornoli A; Menghetti I; Belpoggi F; Redenti S; Roter A
    Pharmacol Res; 2018 Jun; 132():176-187. PubMed ID: 29408497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5.
    Franchin G; Zybarth G; Dai WW; Dubrovsky L; Reiling N; Schmidtmayerova H; Bukrinsky M; Sherry B
    J Immunol; 2000 Mar; 164(5):2592-601. PubMed ID: 10679098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
    Jin J; Colin P; Staropoli I; Lima-Fernandes E; Ferret C; Demir A; Rogée S; Hartley O; Randriamampita C; Scott MG; Marullo S; Sauvonnet N; Arenzana-Seisdedos F; Lagane B; Brelot A
    J Biol Chem; 2014 Jul; 289(27):19042-52. PubMed ID: 24855645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.